Show
Sort by
-
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine
-
2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation
-
What are the limitations on dose escalation to sub-volumes in head and neck cancer : experience from dose painting
-
Randomized phase 2 trial of adaptive dose painting vs. standard IMRT for head and neck cancer
-
TMS dosage influences the change in dopamine
-
- Journal Article
- A1
- open access
PET quantification of [18F]MPPF in the canine brain using blood input and reference tissue modelling
-
- Journal Article
- A1
- open access
Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
-
- Journal Article
- A1
- open access
Cost-effectiveness of [18F] fluoroethyl-L-tyrosine for temozolomide therapy assessment in patients with glioblastoma
-
- Journal Article
- A1
- open access
Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma : a preclinical F98 glioblastoma rat model study
-
Striatal dopamine D2 binding correlates with locus of control : preliminary evidence from [11C]raclopride Positron Emission Tomography